Letter: F.D.P. levels in different types of intravascular hemolysis

Wardle, E N
October 1973
British Medical Journal;10/13/1973, Vol. 4 Issue 5884, p111
Academic Journal
No abstract available.


Related Articles

  • Intravascular Hemolysis Following Endoscopic Variceal Sclerotherapy. Bhatia, V.; Goenka, M. K.; Kochhar, R.; Subbaramaiah, A. H. V.; Mehta, S. K. // American Journal of Gastroenterology;Oct1990, Vol. 85 Issue 10, p1435 

    Presents a letter to the editor about intravascular hemolysis after endoscopic variceal sclerotherapy.

  • Severe intravascular haemolysis following minor group mismatched peripheral blood stem cell transplantation. Nair, V.; Sharma, A.; Ratheesh, J.; Das, S.; Mishra, D. K.; Kale, R.; Grover, N.; Mohan, C. // Bone Marrow Transplantation;Jun2007, Vol. 39 Issue 12, p805 

    A letter to the editor is presented about the case of severe delayed intravascular hemolysis in a minor mismatched peripheral blood stem cell transplantation.

  • Firm insoles effectively reduce hemolysis in runners during long distance running - a comparative study. Janakiraman, Kamal; Shenoy, Shweta; Sandhu, Jaspal Singh // SMARTT: Sports Medicine, Arthroscopy, Rehabilitation, Therapy & ;2011, Vol. 3 Issue 1, p12 

    Background: Shock absorbing insoles are effective in reducing the magnitude and rate of loading of peak impact forces generated at foot strike during running, whereas the foot impact force during running has been considered to be an important cause of intravascular hemolysis in long distance...

  • A case of severe intravascular hemolysis in a young girl. Shastry, Shamee; Bhat, Sudha S. // Asian Journal of Transfusion Science;Jul-Dec2011, Vol. 5 Issue 2, p191 

    A letter to the editor is presented regarding the importance of correlating history and clinical results of a patient with laboratory parameters as demonstrated in the laboratory testing of a patient presenting with severe intravascular hemolysis.

  • Cutoff Values of D-Dimer and FDP in Plasma for the Diagnosis of Thrombosis. Kaneko, Toshihiro; Wada, Hideo; Onishi, Katsuya; Abe, Yasunori; Ota, Satoshi; Yamada, Norikazu; Matsmoto, Takeshi; Katayama, Naoyuki; Sudou, Akihiro; Uchida, Atsumasa; Nobori, Tsutomu // Vascular Disease Prevention;May2008, Vol. 5 Issue 2, p81 

    Fibrin-related markers, such as fibrin and fibrinogen degradation products (FDP) and D-dimer, are considered useful for the diagnosis of thrombosis. However, the evidence for making a diagnosis of thrombosis based on fibrin-related markers is still not yet well established. The plasma...

  • Hemólisis inducida por el ejercicio: relación entre el nivel de actividad de la glucosa-6-fosfato deshidrogenasa y el grado de hemólisis. Bonilla, Javier F.; Palomino, Fernando // Colombia Medica;abr-jun2008, Vol. 39 Issue 2, p135 

    Introduction: Oxidation and hemolysis associated with physical exercise, moderate and severe, have been studied by several investigations, but only in the most recent have been evaluated how the variations of the genetic determined mechanisms for antioxidative enzymatic erytrocytic capacity,...

  • Safety Warnings Issued.  // BioPharm International;Feb2006, Vol. 19 Issue 2, p14 

    The article reports that the United States Food and Drug Administration, Cangene and Baxter Healthcare addressed safety concerns for the prescription of WinRho immune globulin for patients with idiopathic thrombocytopenic purpura. The continued postmarketing safety surveillance has shown rare...

  • Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis. Weltermann, A; Pabinger, I; Geissler, K; Jäger, U; Gisslinger, H; Knöbl, P; Eichinger, S; Kyrle, P A; Valent, P; Speiser, W; Schwarzinger, I; Mannhalter, C; Lechner, K // Leukemia (08876924);Aug98, Vol. 12 Issue 8, p1182 

    Among 379 patients with AML with FAB type M1, 2 and M4-7 diagnosed between 1978 and 1997 in our institution, 19 (5%) had hypofibrinogenemia (HF), ie a fibrinogen level <180 mg/dl. Compared to patients with normal fibrinogen (n = 360) patients with HF had significantly elevated markers of...

  • Practices for Identifying and Rejecting Hemolyzed Specimens Are Highly Variable in Clinical Laboratories. Howanitz, Peter J.; Lehman, Christopher M.; Jones, Bruce A.; Meier, Frederick A.; Horowitz, Gary L. // Archives of Pathology & Laboratory Medicine;Aug2015, Vol. 139 Issue 8, p1014 

    Context.--Hemolysis is an important clinical laboratory quality attribute that influences result reliability. Objective.--To determine hemolysis identification and rejection practices occurring in clinical laboratories. Design.--We used the College of American Pathologists Survey program to...

  • Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E Abid, Shahab; Khan, A. Haleem // American Journal of Gastroenterology;Jun2002, Vol. 97 Issue 6, p1544 

    Hemolytic anemia as a complication of acute hepatitis is not uncommon in patients with glucose-6-phosphate dehydrogenase deficiency. However, severe hemolysis in these patients is rare. We report a cohort of five patients with acute viral hepatitis E who developed severe intravascular hemolysis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics